Sacral neuromodulation for the treatment of faecal incontinence following proctectomy

Colorectal Dis. 2017 May;19(5):O145-O152. doi: 10.1111/codi.13570.

Abstract

Aim: This study assessed the effectiveness of sacral neuromodulation (SNM) for faecal incontinence (FI) following proctectomy with colorectal or coloanal anastomosis.

Methods: An Institutional Review Board (IRB)-approved database identified patients treated for FI following proctectomy (SNM-P) for benign or malignant disease, who were matched 1:1 according to preoperative Cleveland Clinic Florida Faecal Incontinence Scores (CCF-FIS) with patients without proctectomy (SNM-NP). Primary outcome was change in CCF-FIS.

Results: Twelve patients (seven women) were in the SNM-P group and 12 (all women) were in the SNM-NP group. In the SNM-P group, six patients underwent proctectomy for low rectal cancer and five received neoadjuvant chemoradiation. Five patients had handsewn anastomosis, and one had stapled coloanal anastomosis. One lead explantation occurred after a failed 2-week SNM percutaneous trial. Six patients underwent proctectomy for benign conditions. Within-group analyses revealed significant improvement in CCF-FIS in the SNM-P group (reduction from a score of 18 to a score of 14; P = 0.02), which was more profound for benign disease (reduction from 14.5 to 8.5) than for rectal cancer (reduction from 19.5 to 15). SNM was explanted in 66% and 33% of patients after proctectomy for malignant and benign conditions, respectively. In the SNM-NP group, 41% underwent overlapping sphincteroplasty. One patient received chemoradiation for anal cancer. Within-group analysis for the SNM-NP group showed significant improvement in CCF-FIS (a reduction from 17.5 to 4.0; P = 0.003). There was significant improvement in CCF-FIS in patients without previous proctectomy (mean delta CCF-FIS: 11.1 vs 4.7; P = 0.011). Analysis of covariance (ANCOVA) reaffirmed that controls outperformed proctectomy patients (P = 0.006).

Conclusion: SNM for FI after proctectomy appears less effective than SNM in patients without proctectomy, with high device explantation rates, particularly after neoadjuvant chemoradiation and proctectomy for low rectal cancer.

Keywords: Sacral nerve stimulation; chemoradiation; faecal incontinence; low rectal cancer; proctectomy.

Publication types

  • Evaluation Study

MeSH terms

  • Aged
  • Chemoradiotherapy, Adjuvant / adverse effects
  • Fecal Incontinence / therapy*
  • Female
  • Humans
  • Male
  • Middle Aged
  • Postoperative Complications / therapy*
  • Proctocolectomy, Restorative / adverse effects*
  • Prospective Studies
  • Rectal Neoplasms / therapy
  • Retrospective Studies
  • Sacrum / innervation
  • Transcutaneous Electric Nerve Stimulation / methods*
  • Treatment Outcome